| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |